US Food and Drug Administration Black Box Warning and Its Impact on the Use of Erythropoiesis-Stimulating Agents: Thinking Outside the Box

J Clin Oncol. 2017 Oct 1;35(28):3264. doi: 10.1200/JCO.2017.74.3104. Epub 2017 Aug 8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug Labeling
  • Erythropoiesis
  • Erythropoietin*
  • Hematinics*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Hematinics
  • Erythropoietin